These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38787725)

  • 1. Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus.
    Ye T; Zhou J; Guo C; Zhang K; Wang Y; Liu Y; Zhou J; Xie Y; Li E; Gong R; Zhang J; Chuai X; Chiu S
    Cell Rep; 2024 Jun; 43(6):114269. PubMed ID: 38787725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice.
    Zhou J; Ye T; Yang Y; Li E; Zhang K; Wang Y; Chen S; Hu J; Zhang K; Liu F; Gong R; Chuai X; Wang Z; Chiu S
    Mol Ther; 2024 Jun; 32(6):1779-1789. PubMed ID: 38659224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice.
    Yang X; Hu C; Yang X; Yang X; Hu X; Wang X; Liu C; Yuan Y; Du S; Wang PG; Lin J
    J Med Virol; 2023 Oct; 95(10):e29140. PubMed ID: 37800627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational development of multicomponent mRNA vaccine candidates against mpox.
    Zhang RR; Wang ZJ; Zhu YL; Tang W; Zhou C; Zhao SQ; Wu M; Ming T; Deng YQ; Chen Q; Jin NY; Ye Q; Li X; Qin CF
    Emerg Microbes Infect; 2023 Dec; 12(1):2192815. PubMed ID: 36947428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice.
    Xia H; He YR; Zhan XY; Zha GF
    Antiviral Res; 2023 Aug; 216():105668. PubMed ID: 37429529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice.
    Yang X; Yang X; Du S; Hu C; Yang X; Wang X; Hu X; Rcheulishvili N; Wang PG; Lin J
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge.
    Hou F; Zhang Y; Liu X; Murad YM; Xu J; Yu Z; Hua X; Song Y; Ding J; Huang H; Zhao R; Jia W; Yang X
    Nat Commun; 2023 Sep; 14(1):5925. PubMed ID: 37739969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus.
    Sang Y; Zhang Z; Liu F; Lu H; Yu C; Sun H; Long J; Cao Y; Mai J; Miao Y; Wang X; Fang J; Wang Y; Huang W; Yang J; Wang S
    Signal Transduct Target Ther; 2023 Apr; 8(1):172. PubMed ID: 37117161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease.
    Zuiani A; Dulberger CL; De Silva NS; Marquette M; Lu YJ; Palowitch GM; Dokic A; Sanchez-Velazquez R; Schlatterer K; Sarkar S; Kar S; Chawla B; Galeev A; Lindemann C; Rothenberg DA; Diao H; Walls AC; Addona TA; Mensa F; Vogel AB; Stuart LM; van der Most R; Srouji JR; Türeci Ö; Gaynor RB; Şahin U; Poran A
    Cell; 2024 Mar; 187(6):1363-1373.e12. PubMed ID: 38366591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity.
    Zhang N; Cheng X; Zhu Y; Mo O; Yu H; Zhu L; Zhang J; Kuang L; Gao Y; Cao R; Liang X; Wang H; Li H; Li S; Zhong W; Li X; Li X; Hao P
    Sci China Life Sci; 2023 Oct; 66(10):2329-2341. PubMed ID: 37300753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
    Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ
    Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
    Freyn AW; Atyeo C; Earl PL; Americo JL; Chuang GY; Natarajan H; Frey TR; Gall JG; Moliva JI; Hunegnaw R; Asthagiri Arunkumar G; Ogega CO; Nasir A; Santos G; Levin RH; Meni A; Jorquera PA; Bennett H; Johnson JA; Durney MA; Stewart-Jones G; Hooper JW; Colpitts TM; Alter G; Sullivan NJ; Carfi A; Moss B
    Sci Transl Med; 2023 Oct; 15(716):eadg3540. PubMed ID: 37792954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.
    Jacob-Dolan C; Ty D; Hope D; McMahan K; Liu J; Powers OC; Cotter CA; Sciacca M; Wu C; Borducchi E; Bouffard E; Richter H; Velasco J; Teow E; Boursiquot M; Cook A; Feliciano K; Yalley-Ogunro J; Seaman MS; Pessiant L; Lewis MG; Andersen H; Moss B; Barouch DH
    Sci Transl Med; 2024 Mar; 16(740):eadl4317. PubMed ID: 38536937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge.
    Tang D; Liu X; Lu J; Fan H; Xu X; Sun K; Wang R; Li C; Dan D; Du H; Wang Z; Li X; Yang X
    Front Immunol; 2023; 14():1203410. PubMed ID: 37435062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review.
    Wang Y; Yang K; Zhou H
    Int J Biol Macromol; 2023 Aug; 245():125515. PubMed ID: 37353117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoinformatic-guided novel mRNA vaccine designing to elicit immunogenic responses against the endemic Monkeypox virus.
    Aiman S; Ali Y; Malik A; Alkholief M; Ahmad A; Akhtar S; Ali S; Khan A; Li C; Shams S
    J Biomol Struct Dyn; 2024 Aug; 42(12):6292-6306. PubMed ID: 37424185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge.
    Zeng J; Li Y; Jiang L; Luo L; Wang Y; Wang H; Han X; Zhao J; Gu G; Fang M; Huang Q; Yan J
    Emerg Microbes Infect; 2023 Dec; 12(1):2204151. PubMed ID: 37070521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections.
    Zhao R; Wu L; Sun J; Liu D; Han P; Gao Y; Zhang Y; Xu Y; Qu X; Wang H; Chai Y; Chen Z; Gao GF; Wang Q
    Nat Commun; 2024 May; 15(1):4660. PubMed ID: 38821921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus.
    Shchelkunov SN; Sergeev AA; Yakubitskiy SN; Titova KA; Pyankov SA; Kolosova IV; Starostina EV; Borgoyakova MB; Zadorozhny AM; Kisakov DN; Shulgina IS; Karpenko LI
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus.
    Li E; Guo X; Hong D; Gong Q; Xie W; Li T; Wang J; Chuai X; Chiu S
    Signal Transduct Target Ther; 2023 Sep; 8(1):350. PubMed ID: 37709783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.